| Literature DB >> 35178264 |
Ishara Kumarasiri1, Ruwan Samararathna1, Udara Sandakelum1, Oshanie Muthukumarana1, Reha Balasubramaniam1, Sachith Mettananda1,2.
Abstract
INTRODUCTION: Acute disseminated encephalomyelitis is a rare inflammatory demyelinating disease characterized by acute onset polyfocal neurological deficits associated with encephalopathy. It commonly presents with fever, meningism, seizures, ataxia, motor deficits, and bladder dysfunction. Although cranial neuropathies, including optic neuritis and facial nerve palsies, have previously been reported, children presenting with bilateral ptosis is extremely rare. Here, we report a 3-year-old child with acute disseminated encephalomyelitis presenting with acute onset bilateral ptosis due to involvement of the single central levator subnucleus of the oculomotor nerve. Case Presentation. A 3-year-old Sri Lankan boy presented with drooping of the upper eyelids for three days and unsteady gait for two days. He did not have seizures, blurring of vision, limb weakness, swallowing or breathing difficulties, or bladder dysfunction. On examination, he had bilateral ptosis, gait ataxia, and dysmetria. His vision, eye movements, and examination of other cranial nerves were normal. MRI brain revealed high signal intensities involving the subcortical white matter of parietal and occipital lobes, midbrain in the area of single central levator subnucleus of the oculomotor nerve, cerebellar vermis, and right cerebellar hemisphere. Based on the clinical features suggesting polyfocal neurological involvement of the midbrain and cerebellum and characteristic MRI findings, the diagnosis of acute disseminated encephalomyelitis was made. He responded well and rapidly to high-dose intravenous methylprednisolone and showed a complete clinical and radiological recovery.Entities:
Year: 2022 PMID: 35178264 PMCID: PMC8847039 DOI: 10.1155/2022/5492155
Source DB: PubMed Journal: Case Rep Pediatr
Figure 1MRI brain during the acute stage showing high signal intensities in the midbrain at the site of single central levator subnucleus of the oculomotor nerve (arrow).
Figure 2MRI brain performed three months after treatment, showing marked improvement in signal intensity changes in the midbrain.